At what age is Pap (Papanicolau) testing for Human Papillomavirus (HPV) recommended to start?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pap Testing and HPV Screening Age Recommendations

Pap testing for cervical cancer screening should begin at age 21 years, regardless of sexual activity history. 1, 2

Current Age-Based Recommendations

  • Screening should begin at age 21 years, regardless of when sexual activity started, according to the American College of Obstetricians and Gynecologists (ACOG) and American Cancer Society (ACS) 2, 1
  • For women aged 21-29 years, screening should be performed every 2 years 1, 2
  • For women aged 30 years and older with normal results, screening can be extended to every 3 years 1, 2
  • Women aged 30 years and older may also opt for HPV co-testing with Pap test every 5 years 1, 3
  • Screening may be discontinued at age 65-70 years after 3 consecutive normal tests in the last 10 years 1, 2

HPV Testing Recommendations

  • HPV co-testing is not recommended for women under age 30 2
  • HPV testing can be used in conjunction with Pap tests for women aged ≥30 years 2
  • High-risk HPV DNA tests are recommended for the triage of women aged ≥21 years who have ASC-US (atypical squamous cells of undetermined significance) cytology results 2
  • HPV DNA testing is not recommended for women aged <20 years for screening or management of abnormal Pap tests 2

Rationale for Current Age Recommendations

  • The incidence of cervical cancer in women younger than 21 years is extremely low (only 0.1% of all cervical cancer cases) 2, 1
  • The annual incidence is only 1-2 cases per 1,000 females aged 15-19 years 2, 1
  • There are concerns about potential harms from anxiety and unnecessary procedures following positive tests in young women 2, 1
  • Most HPV infections in young women are transient and will resolve spontaneously without causing cervical abnormalities 4, 5

Special Considerations

  • Women with hysterectomy (with cervix removed) for benign reasons can discontinue screening 1, 2
  • Women at high risk (HIV positive, immunocompromised, history of cervical cancer) may require more frequent screening 1, 2
  • Women who have received HPV vaccination should still follow the same screening guidelines as unvaccinated women 2, 5

Evolution of Guidelines

  • Earlier guidelines (pre-2010) recommended screening approximately 3 years after first vaginal intercourse but no later than age 21 years 2
  • Since 2010, major organizations have shifted to recommending starting screening at age 21 years regardless of sexual activity 2, 1
  • The American Cancer Society updated their guidelines in 2020 to recommend starting screening at age 25 years, citing the low incidence of cervical cancer in women under 25 1

Common Pitfalls to Avoid

  • Do not begin screening before age 21, even in sexually active adolescents 2, 1
  • Do not use HPV testing alone as a primary screening test without Pap testing 2
  • Do not assume that HPV vaccination eliminates the need for regular screening 5, 2
  • Do not screen too frequently, as this can lead to unnecessary procedures with potential harm 2, 6
  • Do not discontinue screening prematurely before age 65-70 without adequate prior normal results 2, 1

References

Guideline

Cervical Cancer Screening Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Pap test used for detection of cellular changes associated with human papillomavirus].

Revista medica del Instituto Mexicano del Seguro Social, 2013

Research

Abnormal Pap tests after the HPV vaccine.

Australian family physician, 2009

Research

[Cervical Pap smear in an epidemiologically exposed population: ideas, facts and arguments].

Journal de gynecologie, obstetrique et biologie de la reproduction, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.